Select Page

In the last 20 years, the number of adults diagnosed with diabetes in the US has more than doubled as the American population has aged and become more overweight or obese.

More than 34 million people in the United States have diabetes, making it the 7th leading cause of death. According to the Centers for Disease Control and Prevention (CDC), 1 in 3 American adults have prediabetes – approximately 88 million people – and of those, 84 percent are unaware of it. These numbers are astounding and illustrates that a large amount of the US population is at risk for type 2 diabetes.

In addition to diabetes, millions of people are living with other undiagnosed chronic diseases in this country, and the problem is getting worse every day. According to the CDC, in the US:

  • 1 person dies every 36 secondsfrom cardiovascular disease
  • 37 million people have kidney disease with approximately 90% undiagnosed
  • 3 million people have Hepatitis C, mostly undiagnosed

For health plans, the resulting healthcare costs associated with these diseases are, and will continue to be, staggering. Health plans need modern solutions for screening members that are safe, scalable, and convenient to provide the preventative care their members need.

Testing early and often for chronic diseases improves overall member health, reduces costs, and closes care gaps that ultimately lead to better health outcomes. That’s why BioIQ offers a revolutionary At-Home Prevention Panel to identify and test at-risk populations for prediabetes, diabetes, chronic kidney disease, cardiovascular disease, and hepatitis C with one single at-home test.

The Prevention Panel is a turn-key disease surveillance solution to test at-risk populations and refer identified individuals into the appropriate follow-up care or disease management program. This ultimately impacts cost and outcomes through early identification and intervention of these diseases. Participants can now take control of their health by accessing digital healthcare services, completing lab tests, and viewing results from the comfort of their home.

For BioIQ, diabetes prevention is personal. BioIQ was founded in 2005 by Justin Bellante after his friend and academic mentor suffered a fatal stroke as the result of an undiagnosed diabetic condition. A simple A1c test would have revealed his risk for contracting this devastating disease and could have potentially saved his life. Click here to learn more about the BioIQ story.

If you would like to learn more about how we can help prevent or delay type 2 diabetes and other chronic conditions in your population, leave us a note here.

Share This